Peter J Houghton

Staff Member, Greehey Children's Cancer Research Institute

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Peter J Houghton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

STUDIES IN CHILDHOOD SOLID TUMORS
Houghton, P. J.
Project: Research project
CHEMOTHERAPY OF CHILDHOOD RHABDOMYOSARCOMA
Houghton, P. J.
Project: Research project
CANCER DRUGS ACTIVE AGAINST SIGNAL TRANSDUCTION TARGETS
Houghton, P. J.
Project: Research project
Studies of Childhood Sarcomas
Houghton, P. J.
Project: Research project
PEDIATRIC PRECLINICAL TESTING PROGRAM
Houghton, P. J.
Project: Research project

24815 Citations
82 h-Index
419 Article
37 Review article
7 Comment/debate
4 Editorial
More

Age-associated genes in human mammary gland drive human breast cancer progression
Gu, X., Wang, B., Zhu, H., Zhou, Y., Horning, A. M., Huang, T. H. M., Chen, Y., Houghton, P., Lai, Z., Michalek, J. E. & Sun, L. Z., Jun 15 2020, In: Breast Cancer Research. 22, 1, 64.
Research output: Contribution to journal › Article › peer-review

Open Access
Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway
VanCleave, A., Palmer, M., Fang, F., Torres, H., Rodezno, T., Li, Q., Fuglsby, K., Evans, C., Afeworki, Y., Ross, A., Rao, P., Leiferman, P., Zheng, S., Houghton, P. & Tao, J., Jul 1 2020, In: Oncotarget. 11, 27, p. 2597-2610 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium
Gill, J., Zhang, W., Zhang, Z., Roth, M., Harrison, D. J., Rowshan, S., Erickson, S., Gatto, G., Kurmasheva, R., Houghton, P., Teicher, B., Smith, M. A., Kolb, E. A. & Gorlick, R., Oct 1 2020, In: Pediatric Blood and Cancer. 67, 10, e28606.
Research output: Contribution to journal › Article › peer-review
Evaluation of eribulin combined with irinotecan for treatment of pediatric cancer xenografts
Robles, A. J., Kurmasheva, R. T., Bandyopadhyay, A., Phelps, D. A., Erickson, S. W., Lai, Z., Kurmashev, D., Chen, Y., Smith, M. A. & Houghton, P. J., Jun 15 2020, In: Clinical Cancer Research. 26, 12, p. 3012-3023 12 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium
Kurmasheva, R. T., Bandyopadhyay, A., Favours, E., Pozo, V. D., Ghilu, S., Phelps, D. A., McGeehan, G. M., Erickson, S. W., Smith, M. A. & Houghton, P. J., Jul 1 2020, In: Pediatric Blood and Cancer. 67, 7, e28284.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations

One mouse at a time: new approach to testing potential drugs for children's cancers
Peter J Houghton
10/21/20 → 10/22/20
2 items of Media coverage
Press/Media: Press / Media
2019 election results
Peter J Houghton
2/27/20 → 2/28/20
2 items of Media coverage
Press/Media: Press / Media
Neuroscientist Susan Amara Named AAAS President-Elect
Peter J Houghton
1/28/20
1 item of Media coverage
Press/Media: Press / Media
UF researchers discover breakthrough anticancer drug
Robert A Hromas & Peter J Houghton
1/2/20
1 item of Media coverage
Press/Media: Press / Media
Leukemia, lymphoma squarely in sights of new class of drugs
Robert A Hromas & Peter J Houghton
12/6/19 → 12/9/19
6 items of Media coverage
Press/Media: Press / Media